Vascudyne
PrivateLast Round
Grant
Jun 1, 2025
Total Funding Raised
$14M
Company Overview
Vascudyne is a biotechnology company that develops a bioengineered tissue platform designed to create implantable blood vessels and heart valves for cardiovascular care.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vascudyne Comps
Public and private peers based on sector, stage, and business model.
Vascudyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2025 | ||||
| Series A | Dec 2, 2021 |
Key People
Founding team and executive leadership
Vascudyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 83% MoM.
- Jun 1, 2025
$4M grant received from Congressionally Directed Medical Research Programs.
Vascudyne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vascudyne's valuation, stock price, and market status.
